Biotricity is trading at $0.04, down 19.27%, with no clear catalyst identified.
- Biotricity’s news archive lists no announcement dated October 8, 2026, and provides no company-specific explanation for the decline.
- The broader market is weaker, but index moves are modest; healthcare is higher, so sector strength does not explain the drop.
- No clear catalyst or trading-volume detail is available in the supplied price context.